Medrad, Inc./Possis Medical, Inc. to Co-Sponsor ATTRACT Trial, Evaluating Long-Term Benefits of New Treatments for Deep Vein Thrombosis

PITTSBURGH--(BUSINESS WIRE)--MEDRAD Interventional/Possis, the new endovascular-focused division of MEDRAD, INC., today announced that it is a sponsor of the ATTRACT trial which will evaluate the long-term benefits of using the company’s AngioJet® Rheolytic™ Thrombectomy System in combination with clot-softening drugs to provide more rapid endovascular treatment of Deep Vein Thrombosis (DVT).